Fitzpatrick Alexander A
Insider CIK 1398595 · VRNM Sr. VP General Counsel · EVFM General Counsel and Secretary · SPRY Chief Legal Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2026-06-12 | 2026-06-12 | 3,355 | $10.00 | $33.5K | 90,910 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | A Award deriv | 2026-01-02 | 2026-01-05 | 240,000 | — | $0 | 240,000 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise deriv | 2025-05-20 | 2025-05-22 | 100,000 | — | $0 | 200,000 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2025-05-20 | 2025-05-22 | 102,969 | $14.10 | $1.45M | 89,613 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise | 2025-05-20 | 2025-05-22 | 100,000 | $5.58 | $558.0K | 192,582 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | A Award deriv | 2025-01-02 | 2025-01-03 | 152,300 | — | $0 | 152,300 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | A Award deriv | 2024-01-02 | 2024-01-04 | 300,000 | — | $0 | 300,000 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | P Buy | 2023-09-29 | 2023-10-02 | 46,258 | $3.78 | $174.9K | 89,227 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | P Buy | 2023-09-28 | 2023-10-02 | 40,000 | $3.62 | $144.8K | 42,969 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | A Award deriv | 2023-01-03 | 2023-01-05 | 700,000 | — | $0 | 700,000 | SEC↗ |
| EVFM Evofem Biosciences, Inc. | A Award deriv | 2022-02-18 | 2022-02-23 | 300,000 | — | $0 | 300,000 | SEC↗ |
| EVFM Evofem Biosciences, Inc. | A Award | 2022-02-18 | 2022-02-23 | 300,000 | — | $0 | 516,422 | SEC↗ |
| EVFM Evofem Biosciences, Inc. | D To issuer | 2021-12-31 | 2022-01-04 | 120,000 | — | $0 | 216,422 | SEC↗ |
| EVFM Evofem Biosciences, Inc. | P Buy | 2021-12-20 | 2021-12-20 | 25,000 | $0.39 | $9.8K | 336,422 | SEC↗ |
| EVFM Evofem Biosciences, Inc. | P Buy | 2021-06-10 | 2021-06-10 | 10,000 | $1.03 | $10.3K | 311,422 | SEC↗ |
| EVFM Evofem Biosciences, Inc. | F Tax w/h | 2021-05-20 | 2021-05-21 | 42,120 | $0.86 | $36.2K | 301,422 | SEC↗ |
| EVFM Evofem Biosciences, Inc. | A Award deriv | 2021-02-03 | 2021-02-03 | 150,000 | — | $0 | 150,000 | SEC↗ |
| EVFM Evofem Biosciences, Inc. | A Award | 2021-02-03 | 2021-02-03 | 200,000 | — | $0 | 343,542 | SEC↗ |
| EVFM Evofem Biosciences, Inc. | P Buy | 2020-11-17 | 2020-11-18 | 9,090 | $2.20 | $20.0K | 143,542 | SEC↗ |
| EVFM Evofem Biosciences, Inc. | F Tax w/h | 2020-06-05 | 2020-06-08 | 31,590 | $3.31 | $104.6K | 134,452 | SEC↗ |
| EVFM Evofem Biosciences, Inc. | F Tax w/h | 2020-05-22 | 2020-05-26 | 39,487 | $4.99 | $197.0K | 166,042 | SEC↗ |
| EVFM Evofem Biosciences, Inc. | F Tax w/h | 2020-05-06 | 2020-05-08 | 7,802 | $5.24 | $40.9K | 205,529 | SEC↗ |
| EVFM Evofem Biosciences, Inc. | A Award deriv | 2020-02-05 | 2020-02-07 | 100,000 | — | $0 | 100,000 | SEC↗ |
| EVFM Evofem Biosciences, Inc. | A Award | 2020-02-05 | 2020-02-07 | 150,000 | — | $0 | 213,331 | SEC↗ |
| EVFM Evofem Biosciences, Inc. | F Tax w/h | 2019-11-25 | 2019-11-26 | 7,747 | $6.22 | $48.2K | 63,331 | SEC↗ |
| EVFM Evofem Biosciences, Inc. | F Tax w/h | 2019-11-20 | 2019-11-21 | 7,747 | $5.74 | $44.5K | 71,078 | SEC↗ |
| EVFM Evofem Biosciences, Inc. | F Tax w/h | 2019-10-16 | 2019-10-17 | 18,427 | $5.01 | $92.3K | 78,825 | SEC↗ |
| EVFM Evofem Biosciences, Inc. | F Tax w/h | 2019-08-22 | 2019-08-26 | 1,296 | $5.13 | $6.6K | 97,252 | SEC↗ |
| EVFM Evofem Biosciences, Inc. | F Tax w/h | 2019-06-10 | 2019-06-12 | 7,777 | $6.36 | $49.5K | 98,548 | SEC↗ |
| EVFM Evofem Biosciences, Inc. | F Tax w/h | 2019-04-01 | 2019-04-03 | 1,298 | $3.55 | $4.6K | 106,325 | SEC↗ |
| EVFM Evofem Biosciences, Inc. | A Award | 2019-02-25 | 2019-02-27 | 50,000 | — | $0 | 107,623 | SEC↗ |
| EVFM Evofem Biosciences, Inc. | A Award deriv | 2018-11-28 | 2018-11-29 | 0 | — | $0 | 100,000 | SEC↗ |
| EVFM Evofem Biosciences, Inc. | A Award deriv | 2018-11-28 | 2018-12-03 | 100,000 | — | $0 | 100,000 | SEC↗ |
| EVFM Evofem Biosciences, Inc. | F Tax w/h | 2018-10-16 | 2018-10-17 | 17,377 | $3.78 | $65.7K | 57,623 | SEC↗ |
| EVFM Evofem Biosciences, Inc. | P Buy | 2018-08-21 | 2018-08-21 | 500 | $2.27 | $1.1K | 75,000 | SEC↗ |
| EVFM Evofem Biosciences, Inc. | P Buy | 2018-08-20 | 2018-08-21 | 4,500 | $2.20 | $9.9K | 74,500 | SEC↗ |
| EVFM Evofem Biosciences, Inc. | A Award deriv | 2018-07-31 | 2018-08-02 | 0 | — | $0 | 104,500 | SEC↗ |
| EVFM Evofem Biosciences, Inc. | A Award | 2018-07-02 | 2018-07-03 | 70,000 | — | $0 | 70,000 | SEC↗ |
| EVFM Evofem Biosciences, Inc. | A Award deriv | 2018-03-12 | 2018-03-14 | 275,000 | — | $0 | 275,000 | SEC↗ |
| VRNM VERENIUM CORP | D To issuer deriv | 2013-10-31 | 2013-11-04 | 25,000 | — | $0 | 0 | SEC↗ |
| VRNM VERENIUM CORP | D To issuer deriv | 2013-10-31 | 2013-11-04 | 50,000 | — | $0 | 0 | SEC↗ |
| VRNM VERENIUM CORP | D To issuer deriv | 2013-10-31 | 2013-11-04 | 25,000 | — | $0 | 0 | SEC↗ |
| VRNM VERENIUM CORP | D To issuer deriv | 2013-10-31 | 2013-11-04 | 20,000 | — | $0 | 0 | SEC↗ |
| VRNM VERENIUM CORP | D To issuer | 2013-10-31 | 2013-11-04 | 7,496 | $4.00 | $30.0K | 0 | SEC↗ |
| VRNM VERENIUM CORP | A Award deriv | 2013-08-01 | 2013-08-02 | 25,000 | — | $0 | 25,000 | SEC↗ |
| VRNM VERENIUM CORP | A Award deriv | 2012-08-02 | 2012-08-03 | 20,000 | $4.23 | $84.6K | 20,000 | SEC↗ |